Arrow Mark Colorado Holdings LLC Revance Therapeutics, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

$7.03 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$25.78 - $33.21 $1.89 Million - $2.44 Million	-73,407 Reduced 2.55%	2,806,712 $78.2 Million
Q2 2021 Aug 16, 2021	SELL	$26.8 - $31.84 $7.59 Million - $9.02 Million	-283,136 Reduced 8.95%	2,880,119 $85.4 Million
Q1 2021 May 17, 2021	BUY	$24.03 - $29.97 $4.78 Million - $5.97 Million	199,120 Added 6.72%	3,163,255 $88.4 Million
Q4 2020 Feb 16, 2021	BUY	$23.41 - $28.34 $4.71 Million - $5.71 Million	201,329 Added 7.29%	2,964,135 $84 Million
Q3 2020 Nov 16, 2020	SELL	$23.23 - $34.3 $19 Million - $28 Million	-816,905 Reduced 22.82%	2,762,806 $69.5 Million
Q2 2020 Aug 14, 2020	SELL	$12.6 - $26.55 $2.66 Million - $5.6 Million	-210,937 Reduced 5.56%	3,579,711 $87.4 Million
Q1 2020 May 15, 2020	SELL	$12.46 - $27.81 $13.1 Million - $29.2 Million	-1,049,988 Reduced 21.69%	3,790,648 $56.1 Million
Q4 2019 Feb 14, 2020	BUY	$11.66 - $20.15 $104,741 - $181,007	8,983 Added 0.19%	4,840,636 $78.6 Million
Q3 2019 Nov 14, 2019	BUY	$10.22 - $14.5 $5.32 Million - $7.55 Million	520,657 Added 12.08%	4,831,653 $62.8 Million
Q2 2019 Aug 14, 2019	BUY	$10.67 - $15.49 $9.62 Million - $14 Million	901,779 Added 26.45%	4,310,996 $55.9 Million
Q1 2019 May 15, 2019	BUY	$15.4 - $20.39 $16.9 Million - $22.4 Million	1,098,314 Added 47.53%	3,409,217 $53.7 Million
Q4 2018 Feb 14, 2019	BUY	$18.06 - $24.96 $1.21 Million - $1.68 Million	67,248 Added 3.0%	2,310,903 $46.5 Million
Q3 2018 Nov 14, 2018	BUY	$23.55 - $30.1 $10.3 Million - $13.2 Million	439,380 Added 24.35%	2,243,655 $55.8 Million
Q2 2018 Aug 14, 2018	BUY	$27.45 - $33.35 $1.88 Million - $2.29 Million	68,576 Added 3.95%	1,804,275 $49.5 Million
Q1 2018 May 15, 2018	SELL	$29.15 - $37.4 $30,170 - $38,709	-1,035 Reduced 0.06%	1,735,699 $53.5 Million
Q4 2017 Feb 14, 2018	SELL	$24.55 - $36.3 $9.79 Million - $14.5 Million	-398,787 Reduced 18.67%	1,736,734 $62.1 Million
Q3 2017 Nov 14, 2017	BUY	$22.55 - $28.1 $48.2 Million - $60 Million	2,135,521	2,135,521 $58.8 Million

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

Black Rock Inc. New York, NY

8.57M
Shares

$22 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.73M
Shares

$14.7 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

4.78M
Shares

$12.3 Million
0.0% of portfolio
Fil LTD Hamilton, D0

4.19M
Shares

$10.8 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

4.16M
Shares

$10.7 Million
0.49% of portfolio

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.

Account